Jeffrey Rosenberg, MD
Pain Medicine · Canton, MINPI 1801902911
Payments from drug & device makers
Across 867 payments — averaging $83.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lexicon Pharmaceuticals, Inc.$23K
- Boston Scientific$21K
- Stimwave Technologies Incorporated$6K
- Nutech Spine, Inc.$6K
- AbbVie$2K
- Abbott$2K
- plus $13K from 54 others
What the payments were for
- Royalty or licence$2,0005%
- Consulting fees$5,40012%
- Speaking & faculty fees$12,02527%
- Travel & lodging$3,0027%
- Food & beverage$21,66649%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WaveWriter Alpha Prime 16$7,715
- SiFix$5,600
- Superion Indirect Decompression System$3,600
- GENERAL PAIN MANAGEMENT$2,934
- Superion ISS$1,456
- SPECTRA WAVEWRITER$1,337
- Intracept$956
- GENERAL - THERAPIES$900
- Senza Spinal Cord Stimulation System$668
- Proclaim Family of SCS IPGs$447
- Neuromodulation-Research Only$426
- PROCLAIM$397
- INTELLIS ADAPTIVESTIM$298
- INTELLIS$270
- Nalu Neurostimulation System$262
- WAVEWRITER ALPHA$214
- INCEPTIV$206
- InSpan$167
- FacetFuse$167
- Axium INS DRG IPG$159
How this compares
$72,465 in reported general payments places this provider in the 95th percentile of 139 pain medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 13 | $1,223 |
| Gabapentin | 47 | $537 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $477 |
| Duloxetine Hcl | 16 | $421 |
| Methocarbamol | 14 | $275 |
| Amitriptyline Hcl | 11 | $271 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $253 |
| Tizanidine Hcl | 23 | $224 |
| Meloxicam | 28 | $170 |
| Trazodone Hcl | 15 | $125 |
| Cyclobenzaprine Hcl | 22 | $122 |
| Diazepam | 16 | $10 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Canton
- Joel SaperAnn Arbor$5.7M
- Harry SukumaranRochester Hills$308K
- Bindu Popat LewisGrand Rapids$135K
- Nasir KhatriFlint$133K
- Yijia ChuGrand Rapids$88K
- Mark MounayerSouthfield$85K
- Alexander TurfeWyandotte$41K
- Eric KozfkayWyoming$28K
- Michael SikorskyBloomfield Hills$28K
- Kendall GroseWyandotte$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.